Li, Bao-sheng <br/><br/>
Phase I study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and Capecitabine, Cisplatin for locally advanced esophageal squamous cell carcinoma.  [electronic resource] 

 -  Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology  Dec 2009 
 - 458-61 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0887 
<br/><br/><label>Standard No.: </label>10.1016/j.radonc.2009.08.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Capecitabine<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cisplatin--administration & dosage<br/>Combined Modality Therapy<br/>Deoxycytidine--administration & dosage<br/>Dose Fractionation, Radiation<br/>Esophageal Neoplasms--drug therapy<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Lymphatic Irradiation<br/>Lymphatic Metastasis<br/>Male<br/>Middle Aged<br/>Radiation Injuries<br/>Radiotherapy Dosage<br/>Radiotherapy, Intensity-Modulated<br/>Survival Rate